168 related articles for article (PubMed ID: 12015693)
1. Bacteremia due to viridans group Streptococci with diminished susceptibility to Levofloxacin among neutropenic patients receiving levofloxacin prophylaxis.
Razonable RR; Litzow MR; Khaliq Y; Piper KE; Rouse MS; Patel R
Clin Infect Dis; 2002 Jun; 34(11):1469-74. PubMed ID: 12015693
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and effects on bowel and throat microflora of oral levofloxacin as antibacterial prophylaxis in neutropenic patients with haematological malignancies.
Timmers GJ; Dijstelbloem Y; Simoons-Smit AM; van Winkelhoff AJ; Touw DJ; Vandenbroucke-Grauls CM; Huijgens PC
Bone Marrow Transplant; 2004 Apr; 33(8):847-53. PubMed ID: 14755314
[TBL] [Abstract][Full Text] [Related]
3. Emergence of quinolone resistance among viridans group streptococci isolated from the oropharynx of neutropenic peripheral blood stem cell transplant patients receiving quinolone antimicrobial prophylaxis.
Prabhu RM; Piper KE; Litzow MR; Steckelberg JM; Patel R
Eur J Clin Microbiol Infect Dis; 2005 Dec; 24(12):832-8. PubMed ID: 16331335
[TBL] [Abstract][Full Text] [Related]
4. Abiotrophia bacteremia in a patient with neutropenic fever and antimicrobial susceptibility testing of Abiotrophia isolates.
Murray CK; Walter EA; Crawford S; McElmeel ML; Jorgensen JH
Clin Infect Dis; 2001 May; 32(10):E140-2. PubMed ID: 11317266
[TBL] [Abstract][Full Text] [Related]
5. Serious complications of bacteremia caused by Viridans streptococci in neutropenic patients with cancer.
Marron A; Carratalà J; González-Barca E; Fernández-Sevilla A; Alcaide F; Gudiol F
Clin Infect Dis; 2000 Nov; 31(5):1126-30. PubMed ID: 11073739
[TBL] [Abstract][Full Text] [Related]
6. The spectrum of Gram-positive bloodstream infections in patients with hematologic malignancies, and the in vitro activity of various quinolones against Gram-positive bacteria isolated from cancer patients.
Rolston KV; Yadegarynia D; Kontoyiannis DP; Raad II; Ho DH
Int J Infect Dis; 2006 May; 10(3):223-30. PubMed ID: 16439177
[TBL] [Abstract][Full Text] [Related]
7. Characterization of fluoroquinolone-resistant beta-hemolytic Streptococcus spp. isolated in North America and Europe including the first report of fluoroquinolone-resistant Streptococcus dysgalactiae subspecies equisimilis: report from the SENTRY Antimicrobial Surveillance Program (1997-2004).
Biedenbach DJ; Toleman MA; Walsh TR; Jones RN
Diagn Microbiol Infect Dis; 2006 Jun; 55(2):119-27. PubMed ID: 16530373
[TBL] [Abstract][Full Text] [Related]
8. Moxifloxacin prophylaxis in neutropenic patients.
von Baum H; Sigge A; Bommer M; Kern WV; Marre R; Döhner H; Kern P; Reuter S
J Antimicrob Chemother; 2006 Oct; 58(4):891-4. PubMed ID: 16880172
[TBL] [Abstract][Full Text] [Related]
9. Levofloxacin vs. ciprofloxacin plus phenethicillin for the prevention of bacterial infections in patients with haematological malignancies.
Timmers GJ; Simoons-Smit AM; Leidekker ME; Janssen JJ; Vandenbroucke-Grauls CM; Huijgens PC
Clin Microbiol Infect; 2007 May; 13(5):497-503. PubMed ID: 17263835
[TBL] [Abstract][Full Text] [Related]
10. Dental health and viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients.
Graber CJ; de Almeida KN; Atkinson JC; Javaheri D; Fukuda CD; Gill VJ; Barrett AJ; Bennett JE
Bone Marrow Transplant; 2001 Mar; 27(5):537-42. PubMed ID: 11313689
[TBL] [Abstract][Full Text] [Related]
11. The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit.
Craig M; Cumpston AD; Hobbs GR; Devetten MP; Sarwari AR; Ericson SG
Bone Marrow Transplant; 2007 Apr; 39(8):477-82. PubMed ID: 17322937
[TBL] [Abstract][Full Text] [Related]
12. Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancies.
Reuter S; Kern WV; Sigge A; Döhner H; Marre R; Kern P; von Baum H
Clin Infect Dis; 2005 Apr; 40(8):1087-93. PubMed ID: 15791505
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of bacterial kill when modelling the bronchopulmonary pharmacokinetic profile of moxifloxacin and levofloxacin against parC-containing isolates of Streptococcus pneumoniae.
Deryke CA; Du X; Nicolau DP
J Antimicrob Chemother; 2006 Sep; 58(3):601-9. PubMed ID: 16857688
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamics of levofloxacin against characterized ciprofloxacin-resistant Streptococcus pneumoniae.
Lister PD
Postgrad Med; 2008 Sep; 120(3 Suppl 1):46-52. PubMed ID: 18931471
[TBL] [Abstract][Full Text] [Related]
15. Viridans streptococci in endocarditis and neutropenic sepsis: biofilm formation and effects of antibiotics.
Presterl E; Grisold AJ; Reichmann S; Hirschl AM; Georgopoulos A; Graninger W
J Antimicrob Chemother; 2005 Jan; 55(1):45-50. PubMed ID: 15563519
[TBL] [Abstract][Full Text] [Related]
16. Apparent failure of moxifloxacin to prevent ciprofloxacin- and levofloxacin-susceptible Pseudomonas aeruginosa bacteremia in neutropenic patients undergoing peripheral blood stem cell transplantation.
Prabhu RM; Elliott MA; Patel R
Clin Infect Dis; 2004 Apr; 38(7):1043-5. PubMed ID: 15034845
[No Abstract] [Full Text] [Related]
17. Viridans streptococcus bacteremia in children on chemotherapy for cancer: an underestimated problem.
Ahmed R; Hassall T; Morland B; Gray J
Pediatr Hematol Oncol; 2003 Sep; 20(6):439-44. PubMed ID: 14631617
[TBL] [Abstract][Full Text] [Related]
18. Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital.
Kimura M; Araoka H; Yoshida A; Yamamoto H; Abe M; Okamoto Y; Yuasa M; Kaji D; Kageyama K; Nishida A; Ishiwata K; Takagi S; Yamamoto G; Asano-Mori Y; Uchida N; Hishinuma A; Izutsu K; Wake A; Taniguchi S; Yoneyama A
BMC Infect Dis; 2016 Aug; 16():372. PubMed ID: 27495798
[TBL] [Abstract][Full Text] [Related]
19. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.
Malhotra-Kumar S; Van Heirstraeten L; Lammens C; Chapelle S; Goossens H
J Antimicrob Chemother; 2009 May; 63(5):886-94. PubMed ID: 19279051
[TBL] [Abstract][Full Text] [Related]
20. Clinical features and complications of viridans streptococci bloodstream infection in pediatric hemato-oncology patients.
Huang WT; Chang LY; Hsueh PR; Lu CY; Shao PL; Huang FY; Lee PI; Chen CM; Lee CY; Huang LM
J Microbiol Immunol Infect; 2007 Aug; 40(4):349-54. PubMed ID: 17712470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
